Leuven, Belgium I July 23, 2019
miDiagnostics today announced it has joined the NVIDIA Inception program, which is designed to nurture startups revolutionizing industries with advancements in AI and data sciences.
miDiagnostics is developing a new class of near-patient diagnostic platform based on silicon chips that are embedded in credit card-sized test cards. These silicon chips, called nanoFluidic Processors, can be functionalized to allow for the measurement of virtually any type of biomarker: cells, proteins, nucleic acids and small molecules. The test cards are read by a compact reader for rapid data collection and analysis, outside a laboratory environment, by means of advanced machine learning algorithms.
“We are very excited to be included in this inception program. By tapping into the vast algorithmic know-how and exceptional computational optimization expertise offered by the NVIDIA ecosystem and Inception program, we can further accelerate our software R&D programs. In addition, it will allow us to increase the maturity of our current algorithmic solutions to a commercial-grade level,”
Jan Fransens, Director of Algorithms and Software
NVIDIA’s Inception program is a virtual accelerator program that helps startups during critical stages of product development, prototyping and deployment. Every Inception member gets a custom set of ongoing benefits, from hardware grants and marketing support to training with deep learning experts.